Clinical Trial Update: Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial results are reported for denosumab to prevent osteoporosis in renal transplant recipients; the study is completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Rudolf Wuethrich | Conditions: Osteoporosis, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-04-26